DK0643061T3 - Nye cephalosporin-antibitotika - Google Patents

Nye cephalosporin-antibitotika

Info

Publication number
DK0643061T3
DK0643061T3 DK94114164T DK94114164T DK0643061T3 DK 0643061 T3 DK0643061 T3 DK 0643061T3 DK 94114164 T DK94114164 T DK 94114164T DK 94114164 T DK94114164 T DK 94114164T DK 0643061 T3 DK0643061 T3 DK 0643061T3
Authority
DK
Denmark
Prior art keywords
protecting group
amino
carboxyl
hydroxy
independently
Prior art date
Application number
DK94114164T
Other languages
Danish (da)
English (en)
Inventor
Jong Chan Lim
Hun Seung Oh
Jae Hong Yeo
Chan Sik Bang
Young Min Woo
Deog Ho Yang
Se Ho Kim
Jae Hoon Jeon
Mu Yong Kim
Sam Sik Kim
Tae Hee Lee
Yong Zu Kim
Original Assignee
Lucky Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucky Ltd filed Critical Lucky Ltd
Application granted granted Critical
Publication of DK0643061T3 publication Critical patent/DK0643061T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94114164T 1993-09-11 1994-09-08 Nye cephalosporin-antibitotika DK0643061T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930018321A KR100257130B1 (ko) 1993-09-11 1993-09-11 신규 세팔로스포린계 항생제 및 이의 제조방법

Publications (1)

Publication Number Publication Date
DK0643061T3 true DK0643061T3 (da) 2002-04-29

Family

ID=19363395

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94114164T DK0643061T3 (da) 1993-09-11 1994-09-08 Nye cephalosporin-antibitotika

Country Status (14)

Country Link
US (1) US5541175A (fr)
EP (1) EP0643061B1 (fr)
JP (1) JP2552818B2 (fr)
KR (1) KR100257130B1 (fr)
CN (1) CN1040109C (fr)
AT (1) ATE212637T1 (fr)
AU (1) AU670709B2 (fr)
CA (1) CA2131769C (fr)
DE (1) DE69429753T2 (fr)
DK (1) DK0643061T3 (fr)
ES (1) ES2170758T3 (fr)
PT (1) PT643061E (fr)
RU (1) RU2098420C1 (fr)
TW (1) TW273553B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427680B2 (en) * 2001-01-12 2008-09-23 The Regents Of The University Of California Fluorogenic substrates for BETA-lactamase gene expression
FR2737893B1 (fr) * 1995-08-16 1997-09-12 Roussel Uclaf Nouvelles cephalosporines comportant en position 7, un radical benzyloxyimino substitue, leur procede et intermediaires de preparation, leur application comme medicaments
JP4157177B2 (ja) * 1997-06-04 2008-09-24 大塚化学ホールディングス株式会社 ３−アルケニルセフェム化合物の製造法
KR100347608B1 (ko) * 2000-06-01 2002-08-07 삼화페인트공업주식회사 유화중합방법에 의하여 내부기공을 갖는 미세입자의제조방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
CA2935651A1 (fr) 2007-10-09 2009-04-16 Gladius Pharmaceuticals Corporation Inhibiteurs de beta-lactamase a large spectre
ES2700575T3 (es) 2013-03-12 2019-02-18 Gladius Pharmaceuticals Corp 3-Estiril-cefalosporinas derivadas
CN103709164B (zh) * 2013-12-04 2016-08-24 浙江诚意药业股份有限公司 一种腺嘌呤的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202315A (en) * 1989-05-11 1993-04-13 Lucky, Ltd. Cephalosporin compounds
FR2684995A1 (en) * 1991-12-12 1993-06-18 Roussel Uclaf Cephalosporins containing a ( alpha -carboxy-3,4-dihydroxybenzyloxyimino) group, preparation process and intermediates, application as medicaments and pharmaceutical compositions
US5373001A (en) * 1990-06-15 1994-12-13 Roussel Uclaf Cephalosporins
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
KR930007264B1 (ko) * 1990-08-17 1993-08-04 주식회사 럭키 신규한 세팔로스포린 화합물과 그의 제조방법
US5095012A (en) * 1990-08-23 1992-03-10 Bristol-Myers Squibb Company Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof
EP0508375A3 (en) * 1991-04-12 1992-12-09 Lucky Ltd. Novel cephalosporin compounds and processes for preparation thereof

Also Published As

Publication number Publication date
EP0643061A1 (fr) 1995-03-15
CA2131769A1 (fr) 1995-03-12
AU7286394A (en) 1995-03-30
RU2098420C1 (ru) 1997-12-10
DE69429753T2 (de) 2002-08-29
ATE212637T1 (de) 2002-02-15
RU94032285A (ru) 1996-07-20
DE69429753D1 (de) 2002-03-14
US5541175A (en) 1996-07-30
PT643061E (pt) 2002-07-31
JPH07215876A (ja) 1995-08-15
ES2170758T3 (es) 2002-08-16
CN1040109C (zh) 1998-10-07
KR100257130B1 (ko) 2000-05-15
EP0643061B1 (fr) 2002-01-30
AU670709B2 (en) 1996-07-25
CN1106411A (zh) 1995-08-09
CA2131769C (fr) 1999-12-28
JP2552818B2 (ja) 1996-11-13
TW273553B (fr) 1996-04-01
KR950008517A (ko) 1995-04-17

Similar Documents

Publication Publication Date Title
ATE132150T1 (de) 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen
ATE46696T1 (de) 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung.
NZ247277A (en) Imidazolyl-substituted arylsulphonylamino derivatives of piperidine; methods of preparation and pharmaceutical compositions thereof
AU2505297A (en) Acylated N-hydroxymethyl thalidomide prodrugs having an immunomodulatory effect
HUT67259A (en) 5-amino-8-methyl-7-pyrrolidinyl-quinoline-3-carboxylic acid derivatives and pharmaceutical compositions containing them
DK0643061T3 (da) Nye cephalosporin-antibitotika
IL90424A (en) Cephem derivatives, processes for the preparation thereof and pharmaceutical composition containing the same
NZ229242A (en) N-(5,6,7,8-tetrahydropyrido(2,3-d)pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives and pharmaceutical compositions
NZ512891A (en) S-oxide lipid lowering compounds
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
IL109744A (en) 3-(indole-3-yl) propenoic acid derivatives and pharmaceutical compositions thereof
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
ES2140445T3 (es) Derivados de pirrolidinil-tio-penem con propiedades antibioticas.
DE3665593D1 (en) Peptide immunostimulants
PL330616A1 (en) Beta,beta-disubstituted derivatives of 9-deoxy-9a-n-ethyl-9a-aze-9a-homoerythromycin a, method of obtaining them, pharmaceutic composition and application of such derivatives
ES8600762A1 (es) Un procedimiento para la preparacion de nuevos compuestos de beta-lactama.